Femasys FEMY Stock
Femasys Price Chart
Femasys FEMY Financial and Trading Overview
| Femasys stock price | 1.3 USD |
| Previous Close | 0.64 USD |
| Open | 0.64 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 2900 |
| Day's Range | 0.64 - 0.72 USD |
| 52 Week Range | 0.57 - 2.97 USD |
| Volume | 5.63K USD |
| Avg. Volume | 43.25K USD |
| Market Cap | 9.36M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.75 USD |
FEMY Valuation Measures
| Enterprise Value | -1414300 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2671428 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.94034 |
| Price/Book (mrq) | 0.68165225 |
| Enterprise Value/Revenue | -1.2 |
| Enterprise Value/EBITDA | 0.126 |
Trading Information
Femasys Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -50.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.97 USD |
| 52 Week Low | 0.57 USD |
| 50-Day Moving Average | 0.85 USD |
| 200-Day Moving Average | 1.13 USD |
FEMY Share Statistics
| Avg. Volume (3 month) | 43.25K USD |
| Avg. Daily Volume (10-Days) | 13.65K USD |
| Shares Outstanding | 13.19M |
| Float | 10.94M |
| Short Ratio | 1.11 |
| % Held by Insiders | 17.02% |
| % Held by Institutions | 7.61% |
| Shares Short | 25.97K |
| Short % of Float | 0.23% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -997.55% |
| Gross Margin | 63.99% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.30% |
| Return on Equity (ttm) | -63.91% |
Income Statement
| Revenue (ttm) | 1.18M USD |
| Revenue Per Share (ttm) | 0.1 USD |
| Quarterly Revenue Growth (yoy) | -8.50% |
| Gross Profit (ttm) | 764.28K USD |
| EBITDA | -11209088 USD |
| Net Income Avi to Common (ttm) | -11457397 USD |
| Diluted EPS (ttm) | -0.94 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.16M USD |
| Total Cash Per Share (mrq) | 0.77 USD |
| Total Debt (mrq) | 305.07K USD |
| Total Debt/Equity (mrq) | 2.47 USD |
| Current Ratio (mrq) | 8.019 |
| Book Value Per Share (mrq) | 1.041 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10625589 USD |
| Levered Free Cash Flow (ttm) | -6832809 USD |
Profile of Femasys
| Country | United States |
| State | GA |
| City | Suwanee |
| Address | 3950 Johns Creek Court |
| ZIP | 30024 |
| Phone | 770 500 3910 |
| Website | https://www.femasys.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 34 |
Femasys Inc., a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. In addition, the company provides non-surgical product technologies. It offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Q&A For Femasys Stock
What is a current FEMY stock price?
Femasys FEMY stock price today per share is 1.3 USD.
How to purchase Femasys stock?
You can buy FEMY shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Femasys?
The stock symbol or ticker of Femasys is FEMY.
Which industry does the Femasys company belong to?
The Femasys industry is Medical Instruments & Supplies.
How many shares does Femasys have in circulation?
The max supply of Femasys shares is 22.1M.
What is Femasys Price to Earnings Ratio (PE Ratio)?
Femasys PE Ratio is now.
What was Femasys earnings per share over the trailing 12 months (TTM)?
Femasys EPS is -0.93 USD over the trailing 12 months.
Which sector does the Femasys company belong to?
The Femasys sector is Healthcare.
Femasys FEMY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}